可换股债券初始转股价为11.96港元，较前一交易日收市价11.11港元溢价约7.7%，较前五个交易日平均 收市价溢价约0.0%。全部转换后可获22,734,784股（约0.2亿股），占现有已发行股本约4.96%，完成后 占扩大股本约4.73%。 狮腾控股是一家总部位于新加坡的AI与大数据公司，作为东南亚领先的数字解决方案供应商，为企业 提供数字化营运服务及生成式AI平台。所得款项中，约2.6亿港元将用于投资黄金、黄金支持类及黄金 相关产品。本次发行根据股东大会授予的一般授权实施，预计于相关先决条件达成后完成。 点击查看公告原文>> 来源：新浪港股-好仓工作室 声明：市场有风险，投资需谨慎。 本文为AI大模型基于第三方数据库自动发布，任何在本文出现的信 息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成 个人投资建议。受限于第三方数据库质量等问题，我们无法对数据的真实性及完整性进行分辨或核验， 因此本文内容可能出现不准确、不完整、误导性的内容或信息，具体以公司公告为准。如有疑问，请联 系biz@staff.sina.com.cn。 2025年10月30日，狮腾控股（股份代 ...

2025年前九个月的正常化除息税折旧摊销前盈利减少7.7%，为14.21亿美元，主要受营收表现所影响。 正常化除息税折旧摊销前盈利率减少37个基点至30.3%。百威亚太股权持有人应占正常化溢利由2024年 前九个月的7.77亿美元减少至2025年前九个月的6.78亿美元。百威亚太股权持有人应占溢利由2024年前 九个月的7.42亿美元减少至2025年前九个月的5.94亿美元。 格隆汇10月30日丨百威亚太(01876.HK)发布公告，总销量于2025年前九个月同比减少7.0%，达到66,140 十万公升啤酒，主要因为在中国的业务布局影响，但被印度的表现所部分抵销。于2025年前九个月，收 入同比减少6.6%，达到46.91亿美元，每百升收入则增长0.4%，主要受惠于印度的正面地域组合，以及 亚太地区东部的收入管理措施。 首席执行官及联席主席程衍俊表示："2025年前九个月，我们在中国的业务仍因我们的业务布局及即饮 渠道持续疲弱而面临挑战。在韩国，我们的毛利率扩张，各个渠道的表现均超越行业水平。在印度，我 们延续强劲的增长动能，百威品牌的增长领先行业。我们将继续专注于强化我们的主要产品组合，扩大 我们的非即饮营 ...

Core Viewpoint - LHN (01730) has announced that all conditions for delisting have been met as of October 29, 2025, with the last trading day on the Hong Kong Stock Exchange set for October 30, 2025, and delisting effective from November 4, 2025, at 4:00 PM [1] Summary by Relevant Sections - Delisting Conditions: All conditions for delisting have been fulfilled by October 29, 2025 [1] - Last Trading Day: The final trading day for LHN shares on the Hong Kong Stock Exchange is October 30, 2025 [1] - Effective Delisting Date: Shares will be delisted from the main board of the Hong Kong Stock Exchange on November 4, 2025, at 4:00 PM [1]

Group 1 - Meituan Flash Purchase announced a collaboration with over ten thousand brands to establish "Official Flagship Lightning Warehouses," enabling brands to set up official flagship stores with low-cost entry into instant retail [1] - The rapid growth of instant retail highlights the urgent need for innovation in physical retail operations, prompting industry-wide discussions on how instant retail can assist brands in innovating their operational strategies [1] Group 2 - Seven Fresh Kitchen publicly disclosed its list of food suppliers, covering all major categories including vegetables, meat, grains, oils, and seasonings [2] - The initiative promotes supply chain transparency through a 24-hour live kitchen broadcast, allowing consumers to monitor the cooking process via the JD Takeout app [2] - The three-tiered assurance system of "ingredient transparency," "kitchen transparency," and "cooking transparency" aims to ensure consumer confidence in food safety [2] Group 3 - CP AXTRA, a retail company under Charoen Pokphand Group, announced a strategic partnership with Cainiao to develop advanced digital solutions for smart retail technology in Thailand and Southeast Asia [3] - This collaboration draws on China's e-commerce ecosystem, adapting innovative solutions to meet the unique demands of the Thai and ASEAN markets [3]

智通财经APP讯，LHN(01730)公布，建议除牌的条件已全部于2025年10月29日(星期三)达成。股份于联 交所的最后买卖日期为2025年10月30日(星期四)，而股份将于2025年11月4日(星期二)下午四时正起于联 交所主板撤销上市。 ...

Core Viewpoint - The company, CloudTop New Medicine (云顶新耀), has entered into an exclusive licensing agreement with Visara, Inc. for the development, production, and commercialization of VIS-101, a novel dual-function biopharmaceutical targeting VEGF-A and ANG-2, aimed at treating various eye conditions with improved efficacy compared to first-generation therapies [1] Financial Obligations - The company's payment obligations under the licensing agreement include: - An upfront payment of $7 million (approximately RMB 49.7 million) and reimbursement of up to RMB 24 million for out-of-pocket expenses [1] - Potential development and sales milestone payments of up to $89 million (approximately RMB 632 million) [1] - Potential royalties based on net sales [1] Strategic Collaboration - The strategic collaboration between the company and Visara is expected to provide highly differentiated and commercially attractive assets, enriching the company's late-stage product pipeline [1] - VIS-101 allows the company to expand into the competitive ophthalmology field, which has significant unmet medical needs [1]

Core Viewpoint - The company has entered into an exclusive licensing agreement with Visara, Inc. to develop, produce, and commercialize VIS-101, a novel dual-function biologic targeting VEGF-A and ANG-2, which is expected to provide more durable treatment benefits for patients with wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion [1] Financial Obligations - The company's payment obligations under the exclusive license include: - An upfront payment of $7 million (approximately RMB 49.7 million) and reimbursement of self-paid expenses up to RMB 24 million [1] - Potential development and sales milestone payments of up to $89 million (approximately RMB 632 million) [1] - Potential royalties based on net sales [1] Strategic Collaboration - The board believes that the strategic collaboration with Visara will provide the company with highly differentiated and commercially attractive assets, enriching the company's late-stage product pipeline [1] - VIS-101 allows the company to expand into the competitive ophthalmology field, which has significant unmet medical needs [1]

Core Viewpoint - Yuexiu Property continues to strengthen its investment in its home base, Guangzhou, by acquiring a land parcel in Panyu District for a total price of 1.194 billion yuan, marking its first acquisition in the area since 2022 [1][6]. Group 1: Land Acquisition Details - The acquired land parcel in Dashi covers an area of 38,800 square meters with a planned construction area of 77,400 square meters and a plot ratio of 2.6 [1]. - The starting price for the land was 1.104 billion yuan, with a starting floor price of 14,300 yuan per square meter. The final transaction price was 15,400 yuan per square meter, reflecting a premium rate of 8.15% [1][4]. - This acquisition follows a period of inactivity for Yuexiu Property in Panyu, where it previously exited two land parcels for approximately 5 billion yuan in land tickets [1][6]. Group 2: Market Context and Trends - The Dashi area is characterized by a scarcity of land supply, making this acquisition particularly attractive. The area has seen a significant increase in residential transactions, with 1,279 units sold in the first nine months of the year, doubling from the previous year [4]. - The surrounding area has recorded a total of 2,656 residential transactions in the past 13 months, with an average transaction price of 47,000 yuan per square meter for new homes and 21,300 yuan per square meter for second-hand homes, indicating strong demand [4][5]. - The acquisition aligns with Yuexiu Property's strategy to deepen its investment in Guangzhou, particularly in the Panyu District, where it aims to create a comprehensive product system in collaboration with existing projects [4][5]. Group 3: Financial Performance and Strategic Implications - In the first half of the year, Yuexiu Property reported a revenue of 47.574 billion yuan, a year-on-year increase of 34.6%, but its net profit attributable to shareholders decreased by 25.2% to 1.370 billion yuan [7][8]. - The company has maintained a gross profit margin of over 10%, despite market challenges, and is positioned to compete for prime land parcels, such as the upcoming auction for the "absolute rare" site in Zhujiang New Town [8]. - The current land market in Guangzhou is showing signs of recovery, with increased participation from both state-owned and private enterprises, suggesting a more competitive landscape moving forward [8].

Core Viewpoint - INTL GENIUS (00033.HK) announced the resignation of its auditor, Evergreen (Hong Kong) CPA Limited, effective October 28, 2025, and appointed Zhongzheng Tianheng CPA Limited as the new auditor to fill the vacancy [1] Group 1 - Evergreen (Hong Kong) CPA Limited has resigned as the company's auditor [1] - Zhongzheng Tianheng CPA Limited has been appointed as the new auditor based on the recommendation of the audit committee [1] - The appointment of Zhongzheng Tianheng will be effective from October 28, 2025, until the conclusion of the next annual general meeting [1]

智通财经APP讯，百威亚太(01876)公布2025年前9个月业绩，收入约46.91亿美元，同比减少6.6%;毛利 24.12亿美元，同比减少5.8%;百威亚太股权持有人应占溢利5.94亿美元，同比减少19.95%;百威亚太股权 持有人应占正常化溢利6.78亿美元，同比减少12.74%。 总销量于2025年前九个月减少7.0%，于2025年第三季度减少8.6%，乃受到集团在中国的业务布局及渠 道的影响，但被印度的表现所部分抵销。 2025年前九个月的收入下降6.6%，而每百升收入增加0.4%。于2025年第三季度，收入下降8.4%，而每 百升收入增加0.1%，主要受亚太地区东部的收入管理措施和印度有利的产品组合所推动，但被中国的 表现所部分抵销。 ...